Advocating for a world where intellectual
property law serves the public interest.
The Campaign for Affordable Trastuzumab deplores the ex-parte order of the Delhi High Court on a petition by Swiss pharma major Roche, effectively preventing Biocon from marketing of a biosimilar of the breast cancer drug trastuzumab. [The order is available here: http://lobis.nic.in/dhc/MAN/judgement/06-02-2014/MAN05022014S3552014.pdf] Author KM Gopakumar
Srividhya Ragavan (University of Oklahoma College of Law), Brook Baker (Northeastern University School of Law), and Sean Flynn (American University Washington College of Law) submitted the following statement to the International Trade Commission (ITC) Investigation No. 332-543 on Trade, Investment, and Industrial Policies in India: Effects on the U.S. Economy. The ITC will hold a public hearing […]
[EU Press Release, Link] Nearly 70% of Europeans download or stream films for free, whether legally or illegally, according to a new European Commission study on audience behaviour. It also finds that 40% of smartphone owners and more than 60% of tablet owners watch films on their devices. The study finds that this is not […]
Gilead is reported to be in talks to issue voluntary licenses to Indian generic manufacturers for the production of sofosbuvir, an important new drug to fight hepatitis C. If the intended territorial scope of licenses is only 60 countries, it will be far less than what Gilead first offered through it voluntary licenses for ARVs […]
PRESS RELEASE: Berne Declaration, Swissaid, Bionext, and No-patents-on-seeds: Today a broad coalition consisting of 34 NGO’s, farmers’ and breeders’ organisations from 27 European countries filed an opposition to a pepper-patent from Syngenta. The company patented an insect resistance, which they copied from a wild pepper. Such patents are ethically questionable, increase the seed market concentration, […]
[Marcus Low, Treatment Action Campaign, Link (CC-BY-SA)] We are deeply perturbed by revelations in last Friday’s Mail & Guardian exposing what appears to be a very well-funded, covert plot by foreign pharmaceutical companies and their local subsidiaries to delay a democratic law reform process in South Africa. The law reform concerns the new draft intellectual […]
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources